Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Here are the four latest drugs or medical devices approved by the FDA since Aug. 17:
Rather than issuing a recall, medical device managers rely on their physician-customers to screen out defective products and not use them on patients, a new behavioral study published in the Journal of Operations Management suggests.
Acquired hospitals only save about 1.5 percent annually on common expenses in the healthcare supply chain after a deal — significantly less than hospitals estimate when defending their potential merger, according to a new report by the National Bureau of…
The Texas Drug Utilization Review Board, which recommends medications for the state's Medicaid preferred drug list, is demanding that physicians and others who comment at its meetings disclose their ties to drug companies, according to NPR.
Here are the five latest drugs or medical devices approved by the FDA since Aug. 10:
The "stigma" surrounding cybersecurity disclosures is beginning to wane, encouraging more medical device vendors to release alerts about their products over the past two years, according to a MedCrypt report.
After a yearslong delay, the FDA approved the first generic competitor to Mylan's EpiPen Aug. 16.
Baltimore-based Johns Hopkins Medicine signed a five-year distribution agreement with medical supply provider Medline, the company said Aug. 13.
The FDA approved marketing of the direct-to-consumer smartphone app Natural Cycles as a method of contraception to prevent pregnancy Aug. 10.
After its merger with Federal Street Acquisition Corp. is finalized, Universal Hospital Services, a medical equipment management and services company, will go public, the companies announced Aug. 13.